VIDEOS

VIDEOS

Recorded webinars

Alcohol and other drugs treatment guidelines for working with Aboriginal and Torres Strait Islander people launch

This resource has been developed to support non-Aboriginal service providers in the AOD sector working with Aboriginal and Torres Strait Islander people.
Read more


Cultivating capability

Would you like some practical information on how to support your staff with their capability development while balancing their wellbeing at work in response to COVID-19?
Read more


Managing comorbidity: Tips and tricks for adapting practice in a changing environment

This webinar will provide a brief summary of comorbidity research, along with practical strategies to address comorbid mental health and substance use issues during the COVID-19 pandemic.
Read more


Engaging with clients causing domestic and family violence harm during the COVID-19 pandemic

The COVID-19 pandemic presents new challenges and complexities in working with clients who perpetrate domestic and family violence (DFV). It is widely recognised that rates of DFV are increasing during this time, and that some perpetrators are expanding their tactics of coercive control. How might AOD services and practitioners help to keep those who are causing DFV harm within view, and identify and manage the risk they pose to family members?
Read more


​Participate in the opioid overdose response and take home Naloxone program

Watch this webinar to find out more about the Opioid Overdose Response and Take Home Naloxone program and how your organisation can become a registered provider of Take Home Naloxone.
Read more


​Clinical incident management

Under AOD-Core KPI 4 Clinical Incident Management, organisations are required to have a clinical incident management process in place to manage all clinical incidents, and to report serious clinical incidents.
Read more


Engaging with families and significant others

Learn how to engage with families and significant others of people with substance use issues.
Read more


Depot buprenorphine

Depot buprenorphine is a new long acting formulation of an existing opioid pharmacotherapy, buprenorphine and is available now in specialist OST clinics and NSW Government run prisons. Learn more about how this pharmacotherapy works and discuss the implications for people who receive this treatment.

Presenters: Dr Suzie Hudson (NADA) and NSW Chief Addiction Medicine Specialist, Dr Tony Gill.

Launch video

Support documents


Treating the hype: supports and treatment responses for people impacted by methamphetamine use

Australian Institute of Health and Welfare data list methamphetamine use second only to alcohol as the most common drug of concern in clients attending AOD services in Australia.
Read more


NADAbase dashboards

Learn how to use, analyse and maximise the new NADAbase dashboards.
Read more


Engaging consumers: Tricky or transformational?

Delve into the role of language, consumers and research and hear consumers experiences of engagement.
Read more